Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 3/20 | 0.35 |
| ▸ | CA2 | P00918 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26559272 | 0.81 | MCL1 (0.43) | CA1CA2MEN1KMT2APSMB5 | |
| SCHEMBL13660541 | 0.81 | MCL1 (0.43) | CA1CA2MEN1KMT2APSMB5 | |
| SCHEMBL8533512 | 0.80 | MEN1 (0.52) | TDP1MEN1KMT2APSMB5CYP2C9 | |
| SCHEMBL29312940 | 0.80 | TDP1 (0.38) | TDP1MEN1KMT2APSMB5 | |
| SCHEMBL19057292 | 0.80 | TDP1 (0.38) | TDP1CA1CA2MEN1KMT2A | |
| SCHEMBL4683201 | 0.80 | — | — | |
| SCHEMBL1463416 | 0.78 | CA1 (0.38) | CA1CA2RECQL | |
| SCHEMBL22064537 | 0.78 | CA1 (0.38) | CA1CA2RECQL | |
| SCHEMBL8397363 | 0.77 | TDP1 (0.39) | TDP1MEN1KMT2APSMB5GAA | |
| SCHEMBL27271133 | 0.77 | PSMB5 (0.38) | TDP1MEN1KMT2APSMB5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | TDP1 2663/4885CA1 998/4885CA2 2924/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.